Soy-Based Therapeutic Baby Formulas: Testable Hypotheses Regarding the Pros and Cons.
Soy-Based Therapeutic Baby Formulas: Testable Hypotheses Regarding the Pros and Cons.
复制标题
DOI：
10.3389/fnut.2016.00059
复制
发表时间：
2016
影响因子：
5
通讯作者：
Westmark CJ
中科院分区：
文献类型：
--
作者：
Westmark CJ
以大豆为基础的婴儿配方奶粉自1909年以来一直在美国消费，目前构成了婴儿配方奶粉市场的重要部分。目前正在努力生产转基因大豆，这些大豆生产感兴趣的治疗剂，目的是在以大豆为基础的婴儿配方奶粉平台上提供这些剂。这篇综述文章的三个目的是首先讨论以大豆为基础的婴儿配方奶粉的利弊，然后提出可检验的假设，以确定大豆平台是否适合婴儿给药，最后开始讨论，为这一重要的婴儿营养领域的公共政策提供信息。
Soy-based infant formulas have been consumed in the United States since 1909, and currently constitute a significant portion of the infant formula market. There are efforts underway to generate genetically modified soybeans that produce therapeutic agents of interest with the intent to deliver those agents in a soy-based infant formula platform. The threefold purpose of this review article is to first discuss the pros and cons of soy-based infant formulas, then present testable hypotheses to discern the suitability of a soy platform for drug delivery in babies, and finally start a discussion to inform public policy on this important area of infant nutrition.
影响因子：
--
作者：
Elloumi-Mseddi J;Jellali K;Aifa S
通讯作者：
Aifa S